Orphenadrine Extended-Release Tablets and Ultravist Injection
Determining the interaction of Orphenadrine Extended-Release Tablets and Ultravist Injection and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: orphenadrine
Brand name: Norflex, Banflex, Orphenate, Flexoject, Flexon, Mio-Rel, Myolin, Orfro, Norflex Injectable, Antiflex
Synonyms: Orphenadrine
Generic Name: iopromide
Brand name: Ultravist
Synonyms: Ultravist
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Orphenadrine Extended-Release Tablets-Ultresa
- Orphenadrine Extended-Release Tablets-Umeclidinium
- Orphenadrine Extended-Release Tablets-Umeclidinium and vilanterol
- Orphenadrine Extended-Release Tablets-Umeclidinium and vilanterol Inhalation
- Orphenadrine Extended-Release Tablets-Umeclidinium Bromide
- Orphenadrine Extended-Release Tablets-Umeclidinium Inhalation
- Ultravist Injection-Orphenadrine Injection
- Ultravist Injection-Orphenadrine w/A.C.
- Ultravist Injection-Orphenadrine, aspirin, and caffeine
- Ultravist Injection-Orphenate
- Ultravist Injection-Orphengesic
- Ultravist Injection-Orphengesic Forte